To delineate the downstream effectors through which DIRAS1 mediates OXA resistance in CRC, we performed high-throughput RNA sequencing in DIRAS1-overexpressing (OE-DIRAS1) and control HCT116 cells. This evidence concerns the gene DIRAS1 and colorectal carcinoma.